Concepedia

Joanne M. Munck

JM

16

Publications

983

Citations

16

H-Index

2009

Active since

Affiliations

GW Pharmaceuticals (United Kingdom)(Current)

Newcastle University

AstraZeneca (United Kingdom)

Signature Research (United States)

University of Sheffield

Joanne M. Munck is an author at GW Pharmaceuticals (United Kingdom) specializing in medicine, cell biology, and pharmacology.

Top concepts

Publications per year

2009–2021

16

Publications

16

Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K

Joanne M. Munck, Michael A. Batey, Yan Zhao et al. · Molecular Cancer Therapeutics · 2012 · 128 citations · Full text

, , +15

The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer

Fang Fang, Joanne M. Munck, Jessica Tang et al. · Clinical Cancer Research · 2014 · 96 citations · Full text

Inhibition of HSP90 by AT13387 Delays the Emergence of Resistance to BRAF Inhibitors and Overcomes Resistance to Dual BRAF and MEK Inhibition in Melanoma Models

Tomoko Smyth, Kim H.T. Paraiso, Keisha Hearn et al. · Molecular Cancer Therapeutics · 2014 · 91 citations · Full text

DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival

Liam Cornell, Joanne M. Munck, Clara Alsinet et al. · Clinical Cancer Research · 2014 · 85 citations · Full text

ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

George A. Ward, Edward J. Lewis, Jong Sook Ahn et al. · Molecular Cancer Therapeutics · 2018 · 72 citations

Rows per page

1–5 of 16